Literature DB >> 22248828

Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).

Wen-I Lee1, Jing-Long Huang, Kuo-Wei Yeh, Tang-Her Jaing, Tzou-Yien Lin, Yhu-Chering Huang, Cheng-Hsun Chiu.   

Abstract

Natural human immunity to the mycobacteria group, including Mycobacterium tuberculosis, Bacille Calmette-Guérin (BCG) or nontuberculous mycobacteria (NTM), and/or Salmonella species, relies on the functional IL-12/23-IFN-γ integrity of macrophages (monocyte/dendritic cell) connecting to T lymphocyte/NK cells. Patients with severe forms of primary immunodeficiency diseases (PIDs) have more profound immune defects involving this impaired circuit in patients with severe combined immunodeficiencies (SCID) including complete DiGeorge syndrome, X-linked hyper IgM syndrome (HIGM) (CD40L mutation), CD40 deficiency, immunodeficiency with or without anhidrotic ectodermal dysplasia (NEMO and IKBA mutations), chronic granulomatous disease (CGD) and hyper IgE recurrent infection syndromes (HIES). The patients with severe PIDs have broader diverse infections rather than mycobacterial infections. In contrast, patients with an isolated inborn error of the IL-12/23-IFN-γ pathway are exclusively prone to low-virulence mycobacterial infections and nontyphoid salmonella infections, known as Mendelian susceptibility to the mycobacterial disease (MSMD) phenotype. Restricted defective molecules in the circuit, including IFN-γR1, IFN-γR2, IL-12p40, IL-12R-β1, STAT-1, NEMO, IKBA and the recently discovered CYBB responsible for autophagocytic vacuole and proteolysis, and interferon regulatory factor 8 (IRF8) for dendritic cell immunodeficiency, have been identified in around 60% of patients with the MSMD phenotype. Among all of the patients with PIDs referred for investigation since 1985, we have identified four cases with the specific defect (IFNRG1 for three and IL12RB for one), presenting as both BCG-induced diseases and NTM infections, in addition to some patients with SCID, HIGM, CGD and HIES. Furthermore, manifestations in patients with autoantibodies to IFN-γ (autoAbs-IFN-γ), which is categorized as an anticytokine autoantibody syndrome, can resemble the relatively persistent MSMD phenotype lacking BCG-induced diseases.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22248828     DOI: 10.1016/j.jfma.2011.11.004

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  27 in total

Review 1.  Clinical immunology and multiplex biomarkers of human tuberculosis.

Authors:  Gerhard Walzl; Mariëlle C Haks; Simone A Joosten; Léanie Kleynhans; Katharina Ronacher; Tom H M Ottenhoff
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

Review 2.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

3.  Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells.

Authors:  Michael F Goldberg; Elizabeth K Roeske; Lauren N Ward; Thomas Pengo; Thamotharampillai Dileepan; Dmitri I Kotov; Marc K Jenkins
Journal:  Immunity       Date:  2018-12-11       Impact factor: 31.745

4.  Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies.

Authors:  Ezgi Ulusoy; Neslihan Edeer Karaca; Güzide Aksu; Cengiz Çavuşoğlu; Necil Kütükçüler
Journal:  Turk Pediatri Ars       Date:  2017-09-01

5.  Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.

Authors:  Ana Esteve-Sole; Jordi Anton; Rosa Maria Pino-Ramirez; Judith Sanchez-Manubens; Victoria Fumadó; Claudia Fortuny; María Rios-Barnes; Joan Sanchez-de-Toledo; Mónica Girona-Alarcón; Juan Manuel Mosquera; Silvia Ricart; Cristian Launes; Mariona Fernández de Sevilla; Cristina Jou; Carmen Muñoz-Almagro; Eva González-Roca; Andrea Vergara; Jorge Carrillo; Manel Juan; Daniel Cuadras; Antoni Noguera-Julian; Iolanda Jordan; Laia Alsina
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

6.  Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?

Authors:  P R Z Antas
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

7.  Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Authors:  R O Pinheiro; E B de Oliveira; G Dos Santos; G M Sperandio da Silva; B J de Andrade Silva; R M B Teles; A Milagres; E N Sarno; M P Dalcolmo; E P Sampaio
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

8.  Novel nonsense IL-12Rβ1 mutation associated with recurrent tuberculosis.

Authors:  Noor Ul Akbar; Shahid Niaz Khan; Muhammad Usman Amin; Muhammad Ishfaq; Otavio Cabral-Marques; Lena F Schimke; Asif Iqbal; Ikram Ullah; Mubashir Hussain; Ijaz Ali; Nasar Khan; Nadia El Khawanky; Hazir Rahman; Taj Ali Khan
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

9.  Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.

Authors:  Nioosha Nekooie-Marnany; Caroline Deswarte; Vajiheh Ostadi; Bahram Bagherpour; Elaheh Taleby; Mazdak Ganjalikhani-Hakemi; Tom Le Voyer; Hamid Rahimi; Jérémie Rosain; Zahra Pourmoghadas; Saba Sheikhbahaei; Razieh Khoshnevisan; Daniel Petersheim; Daniel Kotlarz; Christoph Klein; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Jacinta Bustamante; Roya Sherkat
Journal:  J Clin Immunol       Date:  2018-09-25       Impact factor: 8.317

10.  Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.

Authors:  Hanen Ouadani; Imen Ben-Mustapha; Meriem Ben-ali; Leila Ben-khemis; Beya Larguèche; Raoudha Boussoffara; Sonia Maalej; Ilhem Fetni; Saida Hassayoun; Abdelmajid Mahfoudh; Fethi Mellouli; Sadok Yalaoui; Hatem Masmoudi; Mohamed Bejaoui; Mohamed-Ridha Barbouche
Journal:  Immunogenetics       Date:  2015-11-06       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.